Elliot Keith Chartash

This inventor holds 14 USPTO granted patents and 30 published patent applications, plus 2 CIPO patents. Top assignees: Abbvie Biotechnology Ltd, Abbvie Inc., Abbott Laboratories Corporation. Active years: 2010-2016.

USPTO Granted Patents = 14 (Patent Applications = 30)

% Patents Active = 78.6

CIPO Patents = 2 (Patent Applications = 12)

Average Co-Inventor Count = 6.3

ph-index = 9

Forward Citations = 124(Granted Patents)

Location History:

Marietta, GA (US) (2010 - 2016)
Randolph, NJ (US) (2014 - 2016)

Company Filing History:

11 out of 93

Abbvie Biotechnology Ltd

Abbott Laboratories Corporation

patents

4. 1 out of 167

Abbvie Deutschland Gmbh and Co Kg

patents

where one patent can have more than one assignee

Years Active: 2010-2016

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9512216 - Use of TNFα inhibitor (2016-12-06),

2. 9499615 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease (2016-11-22),

3. 9187559 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease (2015-11-17),

4. 9090689 - Use of TNFα inhibitor for treatment of psoriasis (2015-07-28),

5. 9085620 - Use of TNFα inhibitor for treatment of psoriatic arthritis (2015-07-21),

6. 9061005 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease (2015-06-23),

7. 9051368 - Methods for treating psoriasis by administering an antibody which binds an epitope of the p40 subunit of IL-12 and/or IL-23 (2015-06-09),

8. 8986693 - Use of TNFα inhibitor for treatment of psoriasis (2015-03-24),

9. 8961974 - Multiple-variable dose regimen for treating TNFα-related disorders (2015-02-24),

10. 8961973 - Multiple-variable dose regimen for treating TNFα-related disorders (2015-02-24),

11. 8906373 - Use of TNF-alpha inhibitor for treatment of psoriasis (2014-12-09),

12. 8889136 - Multiple-variable dose regimen for treating TNFα-related disorders (2014-11-18),

13. 8557239 - Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23 (2013-10-15),

14. 7776331 - Methods of treating plaque psoriasis (2010-08-17),

Title: The Innovative Mind of Elliot Keith Chartash

Introduction: Elliot Keith Chartash is a distinguished inventor based in Marietta, Georgia. His creative spirit and passion for innovation have led to remarkable contributions in various fields.

Latest Patents: Elliot Keith Chartash holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of interests and expertise.

Career Highlights: Throughout his career, Elliot Keith Chartash has been recognized for his groundbreaking inventions that have significantly impacted industries. His commitment to pushing boundaries and exploring new ideas has set him apart as a visionary inventor.

Collaborations: Elliot Keith Chartash has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Elliot Keith Chartash's innovative spirit and dedication to creating impactful solutions continue to inspire the next generation of inventors. His legacy as a prolific inventor is a testament to the power of creativity and perseverance in driving progress and change.